Related Experiment Videos
A CD48 monoclonal antibody for reduction of graft immunogenicity
P Dreger1, K Viehmann, H Löffler
1Department of Immunology, University of Kiel, FRG.
Transplantation Proceedings
|August 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses.
Bone marrow transplantation·2016
A Modified Approach to Dual Kidney Transplantation.
Transplantation proceedings·2026
Demographic, Clinical, and Allocation Shifts in the US Lung Transplant Waitlist: A National SRTR Study (2012-2023).
Transplantation proceedings·2026
Global Status and Research Trends of Heart Transplantation: A Bibliometrics Analysis.
Transplantation proceedings·2026
Hepatitis B virus reactivation risk in haploidentical versus matched donor transplantation: Impact of universal prophylaxis.
Hematology, transfusion and cell therapy·2026
Correlations between autograft cellular components and post-transplant outcome in patients with systemic non-Hodgkin lymphoma mobilized with on-demand plerixafor: A prospective multicenter GOA study.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study.
Lancet (London, England)·2026